Financial Performance - The company's operating revenue for Q1 2022 was CNY 80,787,848.89, representing a year-on-year increase of 0.66%[5] - The net profit attributable to shareholders was CNY 12,281,757.37, showing a decline of 27.23% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was CNY 11,735,537.84, down 24.87% year-on-year[5] - Basic earnings per share were CNY 0.07, a decrease of 46.15% compared to the same period last year[6] - The diluted earnings per share were also CNY 0.07, reflecting the same percentage decrease[6] - Total operating revenue for Q1 2022 was CNY 80,787,848.89, a slight increase of 0.66% compared to CNY 80,255,090.86 in Q1 2021[21] - Net profit for Q1 2022 was CNY 12,281,757.37, a decrease of 27.06% from CNY 16,877,405.80 in Q1 2021[22] - Basic and diluted earnings per share for Q1 2022 were CNY 0.07, down from CNY 0.13 in Q1 2021[23] Cash Flow and Liquidity - The net cash flow from operating activities reached CNY 14,583,791.57, an increase of 80.44% compared to the previous year[5] - Net cash flow from operating activities for Q1 2022 was $14,583,791.57, an increase from $8,082,544.46 in Q1 2021, representing an increase of 80.9%[26] - Cash received from sales of goods and services in Q1 2022 was CNY 56,941,386.04, a decrease of 2.58% from CNY 58,454,937.38 in Q1 2021[25] - Total cash inflow from financing activities was $83,336,070.17, compared to $240,500,000.00 in the previous year, indicating a decrease of 65.3%[27] - Cash outflow from financing activities totaled $53,592,942.81, down from $200,894,644.40 in Q1 2021, a reduction of 73.3%[27] - The net cash flow from investing activities was -$103,553,542.04, worsening from -$59,693,344.22 in the same period last year, reflecting a decline of 73.5%[26] - Cash and cash equivalents at the end of Q1 2022 stood at $128,144,587.89, down from $40,084,988.45 in Q1 2021, a decrease of 68.1%[27] - The company experienced a net decrease in cash and cash equivalents of $59,118,028.33 in Q1 2022, compared to a decrease of $12,000,585.45 in Q1 2021[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,737,211,870.29, a decrease of 0.53% from the end of the previous year[6] - As of March 31, 2022, the company's total assets amounted to approximately CNY 1,737.21 million, a slight decrease from CNY 1,746.48 million as of December 31, 2021[15] - The company's cash and cash equivalents decreased to CNY 136.39 million from CNY 202.87 million, representing a decline of approximately 32.7%[15] - Total liabilities as of Q1 2022 were CNY 842,964,791.25, a decrease from CNY 864,515,535.45 in the previous year[18] - Total current liabilities decreased to CNY 196,075,902.37 in Q1 2022 from CNY 282,341,700.98 in Q1 2021[18] - Long-term borrowings increased to CNY 629,500,000.00 in Q1 2022, up from CNY 562,750,000.00 in Q1 2021[18] - The company has a long-term equity investment valued at CNY 7.76 million, slightly down from CNY 7.80 million[16] - The company’s fixed assets decreased to CNY 455.58 million from CNY 467.08 million, a decline of approximately 2.7%[16] Research and Development - Research and development expenses totaled CNY 6,242,951.26, which is 29.65% higher than the previous year[6] - The proportion of R&D expenses to operating revenue increased to 7.73%, up by 1.73 percentage points year-on-year[6] - Research and development expenses increased to CNY 6,242,951.26 in Q1 2022, up 29.54% from CNY 4,815,195.04 in Q1 2021[21] Future Outlook - The company has not provided any specific guidance or outlook for future performance in the available documents[14]
瑞华泰(688323) - 2022 Q1 - 季度财报